December 8, 2015 - December 10, 2015

Dr Lal PathLabs IPO Review & Recommendations

Dilip Davda has given "Apply" recommendation to Dr Lal PathLabs IPO.

Dr Lal PathLabs IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	1	0	0	0	0
%	100.00	0.00	0.00	0.00	0.00

Dr Lal PathLabs IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	Apply

Dr Lal PathLabs IPO Review by Dilip Davda (Apply)

[Dilip Davda]

As this is the first company under consumer healthcare diagnosis services sector having established brand and has no listed peers to compare with, it may enjoy the benefit of first mover of the sector and hence may attract fancy of investors. Although it being an expensive offer, moderate investment for short to medium term may be considered.

Read detail review...

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.